Allergic rhinitis and its impact on asthma (ARIA) 2008

J Bousquet, N Khaltaev, AA Cruz, J Denburg… - Allergy, 2008 - Wiley Online Library
Allergic rhinitis is a symptomatic disorder of the nose induced after allergen exposure by an
immunoglobulin E (IgE)-mediated inflammation of the membranes lining the nose (1). It was …

Fuel poverty and human health: a review of recent evidence

C Liddell, C Morris - Energy policy, 2010 - Elsevier
The health impacts of tackling fuel poverty are reviewed, drawing primarily on large-scale
studies completed in the last 10 years. Although physical health effects on adults appear to …

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a …

JM FitzGerald, ER Bleecker, P Nair, S Korn, K Ohta… - The Lancet, 2016 - thelancet.com
Background Benralizumab is a humanised, afucosylated, anti-interleukin-5 receptor α
monoclonal antibody that induces direct, rapid, and nearly complete depletion of …

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a …

ER Bleecker, JM FitzGerald, P Chanez, A Papi… - The Lancet, 2016 - thelancet.com
Background Eosinophilia is associated with worsening asthma severity and decreased lung
function, with increased exacerbation frequency. We assessed the safety and efficacy of …

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

NA Hanania, M Noonan, J Corren, P Korenblat… - Thorax, 2015 - thorax.bmj.com
Introduction In a subset of patients with asthma, standard-of-care treatment does not achieve
disease control, highlighting the need for novel therapeutic approaches. Lebrikizumab is a …

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials …

HK Reddel, DR Taylor, ED Bateman… - American journal of …, 2009 - atsjournals.org
Background: The assessment of asthma control is pivotal to the evaluation of treatment
response in individuals and in clinical trials. Previously, asthma control, severity, and …

Effect of bronchoconstriction on airway remodeling in asthma

CL Grainge, LCK Lau, JA Ward, V Dulay… - … England Journal of …, 2011 - Mass Medical Soc
Background Asthma is characterized pathologically by structural changes in the airway,
termed airway remodeling. These changes are associated with worse long-term clinical …

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized …

H Mosbech, R Deckelmann, F de Blay… - Journal of allergy and …, 2014 - Elsevier
Background Investigations meeting current standards are limited for the effect of house dust
mite (HDM) allergy immunotherapy in asthmatic patients. Objective This trial investigated the …

[HTML][HTML] Innate and adaptive T cells in asthmatic patients: relationship to severity and disease mechanisms

TSC Hinks, X Zhou, KJ Staples, BD Dimitrov… - Journal of allergy and …, 2015 - Elsevier
Background Asthma is a chronic inflammatory disease involving diverse cells and mediators
whose interconnectivity and relationships to asthma severity are unclear. Objective We …

[HTML][HTML] Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1

TSC Hinks, T Brown, LCK Lau, H Rupani… - Journal of Allergy and …, 2016 - Elsevier
Background Disease heterogeneity in patients with severe asthma and its relationship to
inflammatory mechanisms remain poorly understood. Objective We aimed to identify and …